MARKET

HBIO

HBIO

Harvard
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.190
+0.190
+4.75%
After Hours: 4.190 0 0.00% 16:00 08/07 EDT
OPEN
4.030
PREV CLOSE
4.000
HIGH
4.250
LOW
3.911
VOLUME
317.13K
TURNOVER
--
52 WEEK HIGH
4.190
52 WEEK LOW
1.390
MARKET CAP
160.81M
P/E (TTM)
-23.4340
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HBIO stock price target is 4.000 with a high estimate of 4.000 and a low estimate of 4.000.

EPS

HBIO News

More
Harvard Bioscience EPS beats by $0.14, beats on revenue, shares jump 8.5%
Harvard Bioscience (NASDAQ:HBIO): Q2 Non-GAAP EPS of $0.05; GAAP EPS of -$0.04 beats by $0.14. Revenue of $23.3M (-21.2% Y/Y) beats by $1.1M. Shares +8.5%
seekingalpha · 2d ago
Harvard Bioscience Q2 Adj. EPS $0.05 Beats $(0.03) Estimate, Sales $23.31M Beat $22.19M Estimate
Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.03) by 266.67 percent. This is a 25 percent increase over earnings of $0.04 per share from
Benzinga · 2d ago
Harvard Bioscience Q2 Adj. EPS $0.05 Beats $(0.03) Estimate, Sales $23.31M Beat $22.19M Estimate
Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.03) by 266.67 percent. This is a 25 percent increase over earnings of $0.04 per share from
Benzinga · 2d ago
Harvard Bioscience Announces Second Quarter 2020 Financial Results
Accelerated cost reduction, cash conservation actions drive increased operating income, reduced net debt * Operating Income up sequentially and year-over-year on both GAAP and adjusted basis * Cost reduction programs offset expected declines in Academic mark
GlobeNewswire · 2d ago
Harvard Bioscience Schedules Second Quarter 2020 Earnings Conference Call for August 5, 2020 at 8:00 AM ET
HOLLISTON, Mass., July 20, 2020 -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for second quarter ended June 30, 2020 before the market opens on.
GlobeNewswire · 07/20 12:30
Hedge Funds Are Dumping Harvard Bioscience, Inc. (HBIO)
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds
Insider Monkey · 07/05 20:30
Avidity Biosciences, Enviva Partners See Activist Action
RTW Investments disclosed an 11.3% stake in newly public biopharmaceutical firm Avidity. ValueAct Capital raised its stake in biomass firm Enviva.
Barrons.com · 06/27 02:12
Edited Transcript of HBIO earnings conference call or presentation 5-May-20 12:00pm GMT
Thomson Reuters StreetEvents · 06/12 21:43

Industry

Advanced Medical Equipment & Technology
+0.47%
Healthcare Equipment & Supplies
+0.49%

Hot Stocks

Symbol
Price
%Change

About HBIO

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.
More

Webull offers kinds of Harvard Bioscience, Inc. stock information, including NASDAQ:HBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HBIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HBIO stock methods without spending real money on the virtual paper trading platform.